J M Goldman1. Show Affiliations » 1. LRF Centre for Adult Leukaemia, Royal Postgraduate Medical School, London, UK.
Abstract
Entities: Disease
Mesh： See more » Actuarial AnalysisAdolescentAdultAgedBlast Crisis/drug therapyBlast Crisis/surgeryBone Marrow Transplantation/statistics & numerical dataBusulfan/therapeutic useChildChild, PreschoolFemaleHumansHydroxyurea/therapeutic useImmunologic Factors/therapeutic useInfant, NewbornInterferon-alpha/therapeutic useLeukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosisLeukemia, Myelogenous, Chronic, BCR-ABL Positive/geneticsLeukemia, Myelogenous, Chronic, BCR-ABL Positive/mortalityLeukemia, Myelogenous, Chronic, BCR-ABL Positive/pathologyLeukemia, Myelogenous, Chronic, BCR-ABL Positive/therapyLeukemia, Myeloid, Accelerated Phase/drug therapyLeukemia, Myeloid, Accelerated Phase/surgeryMaleMiddle AgedPregnancyPregnancy Complications, Neoplastic/therapyProportional Hazards ModelsRemission InductionSurvival Analysis
Substances： See more » Immunologic FactorsInterferon-alphaBusulfanHydroxyurea
Year: 1994 PMID： 8205007 DOI： 10.1016/0268-960x(94)90004-3
Source DB: PubMed Journal: Blood Rev ISSN： 0268-960X Impact factor: 8.250